What is Preformed Line Products' operating income?

Preformed Line Products' total operating income in 2025 was $55.14 million, based on the following breakdown: Total Gross Profit: $208.54 million Total Operating Expenses: $153.40 million

Preformed Line Products (PLPC) Financials

$355.32 -13.15 (-3.57%)

As of 03:20 PM Eastern

Compare

Annual Income Statements for Preformed Line Products

This table shows Preformed Line Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	6.68	15	13	27	23	30	36	54	63	37	35
Consolidated Net Income / (Loss)	6.68	15	13	27	23	30	36	54	63	37	35
Net Income / (Loss) Continuing Operations	6.68	15	13	27	23	30	36	54	63	37	35
Total Pre-Tax Income	12	21	26	33	31	41	49	74	82	51	46
Total Operating Income	12	21	26	33	33	40	48	69	84	51	55
Total Gross Profit	103	109	119	132	141	154	166	215	235	190	209
Total Revenue	355	337	378	421	445	466	517	637	670	594	669
Operating Revenue	355	337	378	421	445	466	517	637	670	594	669
Total Cost of Revenue	251	227	260	289	304	312	351	422	435	404	461
Operating Cost of Revenue	251	227	260	289	304	312	351	422	435	404	461
Total Operating Expenses	91	88	93	99	108	114	119	146	151	139	153
Selling, General & Admin Expense	37	42	43	45	52	56	55	70	75	67	75
Marketing Expense	31	32	34	36	37	36	41	46	51	49	52
Research & Development Expense	15	14	14	15	17	18	19	20	22	22	24
Other Operating Expenses / (Income)	8.75	0.05	0.99	2.43	2.37	4.21	3.71	3.60	2.49	0.93	2.53
Total Other Income / (Expense), net	-0.64	-0.53	-0.30	-0.35	-1.17	0.36	1.35	4.34	-1.81	0.01	-9.52
Interest Expense	0.57	0.84	1.06	1.29	2.22	2.40	2.02	3.21	3.91	2.22	1.30
Interest & Investment Income	0.39	0.29	0.43	0.49	0.78	0.26	0.17	0.63	1.81	2.57	2.32
Other Income / (Expense), net	-0.47	0.03	0.33	0.46	0.27	2.50	3.20	6.93	0.28	-0.34	-11
Income Tax Expense	5.03	5.70	13	6.01	8.12	11	13	19	19	14	10
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	0.00	0.00	0.03	-0.04	-0.01	0.00	0.01	0.02	0.02
Basic Earnings per Share	$1.25	$2.95	$2.48	-	$4.63	$6.05	$7.28	$11.03	$12.87	$7.56	$7.17
Weighted Average Basic Shares Outstanding	5.35M	5.17M	5.10M	5.03M	5.03M	4.92M	4.91M	4.93M	4.92M	4.91M	4.92M
Diluted Earnings per Share	$1.24	$2.95	$2.47	-	$4.58	$5.98	$7.19	$10.88	$12.68	$7.50	$7.14
Weighted Average Diluted Shares Outstanding	5.37M	5.18M	5.13M	5.11M	5.09M	4.98M	4.97M	5.00M	5.00M	4.95M	4.94M
Weighted Average Basic & Diluted Shares Outstanding	5.30M	5.20M	5.10M	5M	5.02M	4.93M	4.91M	4.92M	4.90M	4.94M	4.90M
Cash Dividends to Common per Share	$0.80	$0.80	$0.80	$0.80	-	-	-	$0.80	$0.80	$0.80	$0.81

This table shows Preformed Line Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	6.33	9.60	9.37	7.68	10	12	13	2.63	8.44	11	22
Consolidated Net Income / (Loss)	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11	22
Net Income / (Loss) Continuing Operations	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11	22
Total Pre-Tax Income	6.97	12	11	10	17	14	17	2.36	12	14	28
Total Operating Income	6.95	12	11	10	18	13	17	13	12	14	28
Total Gross Profit	48	44	44	46	56	49	55	53	52	55	73
Total Revenue	146	141	139	147	167	149	170	178	173	176	213
Operating Revenue	146	141	139	147	167	149	170	178	173	176	213
Total Cost of Revenue	98	97	94	101	111	100	114	125	121	121	140
Operating Cost of Revenue	98	97	94	101	111	100	114	125	121	121	140
Total Operating Expenses	41	33	33	35	38	36	38	40	40	42	45
Selling, General & Admin Expense	20	17	15	16	19	18	19	19	20	21	22
Marketing Expense	13	12	12	12	13	12	13	13	13	14	15
Research & Development Expense	5.69	5.43	5.36	5.55	5.59	5.48	5.70	6.18	6.33	6.74	7.16
Other Operating Expenses / (Income)	2.50	-1.37	0.45	1.11	0.75	0.26	0.82	1.13	0.32	-0.05	1.04
Total Other Income / (Expense), net	0.02	0.30	-0.13	0.04	-0.19	0.54	0.18	-11	0.54	0.61	0.54
Interest Expense	0.71	0.71	0.57	0.56	0.38	0.38	0.32	0.31	0.30	0.23	0.24
Interest & Investment Income	0.61	0.97	0.35	0.54	0.72	0.51	0.38	0.68	0.74	0.78	0.63
Other Income / (Expense), net	0.12	0.04	0.09	0.06	-0.53	0.41	0.12	-11	0.10	0.07	0.15
Income Tax Expense	0.66	2.26	1.79	2.73	6.88	2.12	4.61	-0.26	3.85	3.78	6.94
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.02	0.01	0.00	0.02	-0.01	0.04	-0.01	-0.01	-	0.03	0.00
Basic Earnings per Share	$1.32	$1.95	$1.91	$1.57	$2.13	$2.34	$2.58	$0.53	$1.72	$2.15	$4.51
Weighted Average Basic Shares Outstanding	4.92M	4.92M	4.92M	4.90M	4.91M	4.93M	4.93M	4.92M	4.92M	4.91M	4.77M
Diluted Earnings per Share	$1.29	$1.94	$1.89	$1.54	$2.13	$2.33	$2.56	$0.53	$1.72	$2.14	$4.49
Weighted Average Diluted Shares Outstanding	5.00M	4.94M	4.96M	4.98M	4.95M	4.95M	4.96M	4.94M	4.94M	4.93M	4.79M
Weighted Average Basic & Diluted Shares Outstanding	4.90M	4.92M	4.91M	4.90M	4.94M	4.94M	4.92M	4.90M	4.90M	4.89M	4.89M

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.75	0.35	12	-0.10	-4.65	5.91	-8.77	0.83	16	3.64	26
Net Cash From Operating Activities	20	26	34	23	27	42	34	26	108	67	73
Net Cash From Continuing Operating Activities	20	26	34	23	27	42	34	26	108	67	73
Net Income / (Loss) Continuing Operations	6.68	15	13	27	23	30	36	54	63	37	35
Consolidated Net Income / (Loss)	6.68	15	13	27	23	30	36	54	63	37	35
Depreciation Expense	12	12	13	12	14	14	16	16	19	21	23
Non-Cash Adjustments To Reconcile Net Income	4.14	6.81	5.80	7.88	8.11	9.29	11	12	14	6.12	20
Changes in Operating Assets and Liabilities, net	-2.11	-8.08	2.59	-24	-18	-11	-28	-56	11	3.42	-4.85
Net Cash From Investing Activities	-11	-28	-2.56	-14	-49	-14	-18	-47	-45	-12	-43
Net Cash From Continuing Investing Activities	-11	-28	-2.56	-14	-49	-14	-18	-47	-45	-12	-43
Purchase of Property, Plant & Equipment	-11	-25	-11	-9.53	-29	-25	-18	-41	-35	-15	-40
Acquisitions	0.00	-	0.00	0.00	-19	0.00	0.00	-16	-12	0.00	-4.75
Purchase of Investments	-	0.00	0.00	-4.69	-0.50	-	-	0.00	0.00	-3.15	-0.45
Sale of Property, Plant & Equipment	0.93	0.07	0.14	0.20	0.05	11	0.14	3.17	2.63	3.45	0.27
Sale and/or Maturity of Investments	-	0.00	0.00	2.95	2.31	-	-	0.00	0.00	1.99	1.68
Net Cash From Financing Activities	-13	4.39	-20	-9.05	18	-23	-23	23	-49	-48	-9.23
Net Cash From Continuing Financing Activities	-13	4.39	-20	-9.05	18	-23	-23	23	-49	-48	-9.23
Repayment of Debt	-53	-58	-65	-85	-64	-110	-114	-154	-197	-133	-15
Repurchase of Common Equity	-7.55	-5.07	-8.48	-4.17	-6.83	-9.46	-5.27	-5.47	-19	-8.61	-14
Payment of Dividends	-4.39	-4.17	-4.10	-4.09	-4.23	-4.18	-4.13	-4.10	-4.11	-4.08	-4.12
Issuance of Debt	52	71	56	84	93	100	99	185	169	97	22
Issuance of Common Equity	0.08	0.25	1.96	0.22	0.21	0.25	0.41	0.81	2.16	0.21	1.93
Other Net Changes in Cash	-	-1.54	-	-	-0.78	-	-0.89	-1.11	2.44	-3.68	5.29

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	9.87	-7.75	1.57	0.07	9.75	-2.41	12	6.04	10	-14	6.76
Net Cash From Operating Activities	19	5.75	28	9.37	24	5.66	27	19	22	6.05	25
Net Cash From Continuing Operating Activities	19	5.75	28	9.37	24	5.66	27	19	22	6.05	25
Net Income / (Loss) Continuing Operations	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11	22
Consolidated Net Income / (Loss)	6.31	9.60	9.37	7.70	10	12	13	2.62	8.44	11	22
Depreciation Expense	5.31	5.41	5.25	5.32	4.85	5.40	5.69	5.81	6.14	6.17	6.25
Non-Cash Adjustments To Reconcile Net Income	6.58	-0.23	0.16	1.08	5.11	0.63	3.00	15	1.26	2.73	2.34
Changes in Operating Assets and Liabilities, net	1.09	-9.03	14	-4.73	3.67	-12	5.55	-4.58	6.11	-13	-4.88
Net Cash From Investing Activities	-8.09	-0.68	-3.60	-3.45	-4.63	-9.66	-13	-11	-10	-9.94	-16
Net Cash From Continuing Investing Activities	-8.09	-0.68	-3.60	-3.45	-4.63	-9.66	-13	-11	-10	-9.94	-16
Purchase of Property, Plant & Equipment	-8.21	-3.92	-3.73	-3.57	-3.43	-11	-8.38	-11	-10	-9.99	-6.96
Sale of Property, Plant & Equipment	0.13	3.24	0.13	0.13	-0.04	0.09	0.01	0.23	-0.05	0.05	0.04
Net Cash From Financing Activities	-3.38	-12	-22	-7.30	-7.00	-0.02	-4.77	-2.55	-1.89	-9.96	-3.05
Net Cash From Continuing Financing Activities	-3.38	-12	-22	-7.30	-7.00	-0.02	-4.77	-2.55	-1.89	-9.96	-3.05
Repayment of Debt	-46	-38	-45	-45	-8.11	-2.74	-3.73	-5.49	-2.83	-1.43	-0.70
Repurchase of Common Equity	-0.49	-5.45	-0.57	-2.23	-0.35	-4.81	-2.35	-4.51	-2.78	-13	-3.29
Payment of Dividends	-0.98	-1.13	-0.98	-0.98	-0.98	-1.16	-0.99	-0.99	-0.98	-1.12	-1.03
Issuance of Debt	44	33	25	41	2.39	8.63	2.21	8.20	3.17	5.00	1.79
Issuance of Common Equity	0.14	0.06	0.00	0.10	0.05	0.07	0.09	0.24	1.53	0.45	0.18

This table presents Preformed Line Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	323	341	360	359	434	461	489	568	603	574	654
Total Current Assets	180	189	207	214	232	256	272	328	325	316	363
Restricted Cash	-	-	-	-	-	45	36	37	54	57	83
Accounts Receivable	64	63	74	73	84	93	98	125	107	111	113
Inventories, net	70	74	78	85	96	98	115	147	149	130	149
Prepaid Expenses	4.03	3.35	3.43	6.21	6.92	18	20	13	8.25	12	13
Other Current Assets	6.34	8.44	2.21	2.88	4.29	3.26	3.22	4.93	7.26	5.51	5.21
Plant, Property, & Equipment, net	92	105	109	103	124	126	150	175	208	195	223
Total Noncurrent Assets	52	47	44	42	78	79	67	65	70	63	67
Goodwill	16	16	17	16	28	30	28	28	29	27	31
Intangible Assets	11	10	10	8.46	15	14	12	14	13	9.66	10
Noncurrent Deferred & Refundable Income Taxes	13	10	7.77	6.90	7.56	11	3.84	5.32	7.11	6.55	7.48
Other Noncurrent Operating Assets	12	10	9.72	11	27	24	23	18	21	20	19
Total Liabilities & Shareholders' Equity	323	341	360	359	434	461	489	568	603	574	654
Total Liabilities	104	117	121	109	165	169	173	210	187	152	178
Total Current Liabilities	52	55	63	69	81	104	106	115	111	108	115
Short-Term Debt	0.52	2.76	2.31	10	12	23	20	21	13	10	6.61
Accounts Payable	20	22	25	26	28	32	42	47	38	42	50
Accrued Expenses	13	12	15	13	17	18	18	18	27	26	22
Dividends Payable	1.06	1.04	1.05	1.05	1.17	1.29	1.30	1.32	1.30	1.29	1.28
Current Deferred & Payable Income Tax Liabilities	1.42	1.06	1.90	0.82	1.76	5.46	1.11	2.47	1.67	1.96	3.97
Current Employee Benefit Liabilities	15	16	18	18	19	23	22	24	28	26	29
Other Current Liabilities	-	-	-	0.00	2.06	2.24	1.99	1.61	1.67	1.59	1.72
Total Noncurrent Liabilities	53	62	58	40	84	65	67	95	76	43	63
Long-Term Debt	32	43	35	25	54	33	40	68	49	18	33
Noncurrent Deferred & Payable Income Tax Liabilities	2.47	2.08	2.09	1.71	3.12	2.92	2.79	4.17	3.54	3.77	5.71
Other Noncurrent Operating Liabilities	6.87	6.50	11	8.01	22	23	21	22	23	21	25
Total Equity & Noncontrolling Interests	219	224	239	249	269	292	316	359	416	422	476
Total Preferred & Common Equity	219	224	239	249	269	292	316	359	416	422	476
Total Common Equity	219	224	239	249	269	292	316	359	416	422	476
Common Stock	35	37	42	47	52	56	61	67	75	79	81
Retained Earnings	292	303	312	334	353	379	411	461	520	553	584
Treasury Stock	-55	-60	-68	-72	-79	-89	-94	-99	-118	-127	-137
Accumulated Other Comprehensive Income / (Loss)	-54	-57	-47	-60	-57	-55	-62	-70	-60	-83	-53
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	-	-	-	0.00	0.03	-0.01	-0.02	-0.01	-0.01	0.01	0.03

This table presents Preformed Line Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	602	622	607	586	573	592	592	631	645	662	697
Total Current Assets	339	353	338	314	305	321	327	353	360	371	397
Restricted Cash	32	43	44	46	-	47	55	67	73	69	76
Accounts Receivable	141	145	126	112	101	111	119	124	121	131	151
Inventories, net	150	148	150	142	142	143	135	143	146	152	148
Prepaid Expenses	8.30	8.75	8.33	8.31	7.39	13	12	13	14	13	14
Other Current Assets	8.18	8.44	10	7.05	6.98	6.48	6.02	6.28	6.33	6.29	7.73
Plant, Property, & Equipment, net	196	200	201	203	200	201	203	212	218	225	228
Total Noncurrent Assets	67	68	67	69	67	70	63	66	67	65	73
Goodwill	29	30	28	29	28	29	28	30	30	30	36
Intangible Assets	14	14	13	12	11	11	9.74	9.97	9.67	9.84	9.46
Noncurrent Deferred & Refundable Income Taxes	6.15	6.42	6.93	7.38	7.72	9.50	6.28	7.20	7.31	6.79	7.21
Other Noncurrent Operating Assets	17	18	19	21	20	21	19	20	19	18	20
Total Liabilities & Shareholders' Equity	602	622	607	586	573	592	592	631	645	662	697
Total Liabilities	222	223	207	173	156	163	157	171	178	188	203
Total Current Liabilities	125	127	136	100	104	114	106	115	116	124	133
Short-Term Debt	17	21	18	8.57	9.75	11	9.22	8.34	7.51	7.21	6.86
Accounts Payable	56	50	51	42	43	42	45	51	49	57	56
Accrued Expenses	19	23	27	21	23	26	27	26	24	30	37
Dividends Payable	1.19	1.23	1.26	1.19	1.22	1.26	1.15	1.17	1.20	1.18	1.20
Current Deferred & Payable Income Tax Liabilities	7.80	5.79	6.76	2.36	1.53	2.35	1.15	1.17	1.90	3.17	1.15
Current Employee Benefit Liabilities	22	25	30	23	24	29	21	26	31	24	29
Other Current Liabilities	1.54	1.19	1.63	1.53	1.56	1.61	1.75	1.80	1.80	1.55	1.88
Total Noncurrent Liabilities	96	97	71	73	52	49	51	56	62	65	70
Long-Term Debt	68	69	45	48	29	25	26	28	31	35	36
Noncurrent Deferred & Payable Income Tax Liabilities	3.51	3.31	2.98	3.41	2.21	2.84	3.02	3.50	5.66	5.46	5.63
Other Noncurrent Operating Liabilities	17	24	15	14	21	15	16	25	19	19	29
Total Equity & Noncontrolling Interests	381	398	400	413	416	429	436	461	466	474	495
Total Preferred & Common Equity	381	398	400	413	416	429	436	461	466	474	495
Total Common Equity	381	398	400	413	416	429	436	461	466	474	495
Common Stock	68	70	73	75	76	77	76	78	79	80	82
Retained Earnings	481	501	515	529	537	544	564	575	577	594	614
Treasury Stock	-103	-109	-118	-124	-124	-127	-128	-130	-135	-145	-149
Accumulated Other Comprehensive Income / (Loss)	-66	-64	-70	-67	-73	-65	-76	-62	-55	-55	-54
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	0.01	0.00	0.02	-0.00	0.00	0.02	0.05	0.04	0.03	0.06	0.06

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	4,901,871.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	4,901,871.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	7.20
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	7.04	16	13	27	24	29	35	51	65	37	43
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	11.42%	13.53%	8.23%	8.29%
Earnings before Interest and Taxes (EBIT)	12	22	26	33	33	43	51	76	84	50	45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	23	34	39	46	47	57	66	93	103	71	68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	33	-1.99	20	17	-30	22	-1.68	-20	51	68	4.71
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	222	240	232	242	297	304	341	412	426	395	433
Increase / (Decrease) in Invested Capital	-26	18	-7.41	10	54	7.58	36	72	14	-31	38
Book Value per Share	$41.54	$43.66	$46.85	$49.75	$53.62	$59.43	$64.51	$72.90	$85.04	$86.23	$97.01
Tangible Book Value per Share	$36.39	$38.53	$41.63	$44.95	$45.04	$50.49	$56.30	$64.34	$76.36	$78.81	$88.68
Total Capital	251	269	275	285	334	348	376	448	478	451	515
Total Debt	32	46	37	35	66	56	60	90	62	29	39
Total Long-Term Debt	32	43	35	25	54	33	40	68	49	18	33
Net Debt	1.88	15	-7.45	-8.16	27	11	23	52	8.64	-29	-44
Capital Expenditures (CapEx)	9.83	25	11	9.33	29	14	18	37	33	11	40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	98	106	102	112	124	130	150	197	173	160	172
Debt-free Net Working Capital (DFNWC)	129	136	147	155	163	175	186	234	227	218	255
Net Working Capital (NWC)	128	134	144	145	151	153	167	213	213	207	249
Net Nonoperating Expense (NNE)	0.37	0.38	0.15	0.28	0.87	-0.27	-0.98	-3.21	1.39	-0.01	7.36
Net Nonoperating Obligations (NNO)	2.94	16	-6.40	-7.11	28	12	24	54	9.94	-27	-43
Total Depreciation and Amortization (D&A)	12	12	13	12	14	14	16	16	19	21	23
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.25	$2.95	$2.48	$5.28	$4.63	$0.00	$7.28	$11.03	$12.87	$7.56	$7.17
Adjusted Weighted Average Basic Shares Outstanding	5.35M	5.17M	5.10M	5.03M	5.03M	4.92M	4.91M	4.93M	4.92M	4.91M	4.92M
Adjusted Diluted Earnings per Share	$1.24	$2.95	$2.47	$5.21	$4.58	$0.00	$7.19	$10.88	$12.68	$7.50	$7.14
Adjusted Weighted Average Diluted Shares Outstanding	5.37M	5.18M	5.13M	5.11M	5.09M	4.98M	4.97M	5.00M	5.00M	4.95M	4.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	5.21M	5.12M	5.04M	5.06M	5.02M	4.93M	4.91M	4.92M	4.90M	4.94M	4.90M
Normalized Net Operating Profit after Tax (NOPAT)	7.04	16	18	27	24	29	35	56	65	37	43
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	4,901,871.00	4,896,855.00	4,888,012.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	4,901,871.00	4,896,855.00	4,888,012.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	1.72	2.15	4.40
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.31%	-22.51%	-23.70%	-8.39%	14.78%	5.42%	22.26%	21.17%	-	18.67%	25.40%
EBITDA Growth	-60.41%	-48.92%	-49.53%	-36.21%	76.40%	11.32%	37.87%	-50.62%	-	5.37%	49.63%
EBIT Growth	-71.76%	-60.05%	-59.71%	-47.97%	140.41%	16.76%	51.45%	-81.02%	-	1.83%	62.71%
NOPAT Growth	-62.45%	-57.39%	-54.69%	-50.64%	67.91%	18.53%	32.60%	90.38%	-	-9.00%	67.88%
Net Income Growth	-61.74%	-55.17%	-54.23%	-49.18%	65.56%	20.31%	35.58%	-65.97%	-	-8.69%	69.35%
EPS Growth	-60.43%	-54.67%	-53.68%	-49.17%	65.12%	20.10%	35.45%	-65.58%	-	-8.15%	75.39%
Operating Cash Flow Growth	13.25%	-77.38%	38.56%	-77.96%	24.78%	-1.70%	-4.83%	102.22%	-	6.93%	-6.36%
Free Cash Flow Firm Growth	86.21%	149.08%	207.32%	138.86%	651.10%	4.88%	-121.53%	-100.75%	-	-194.99%	0.97%
Invested Capital Growth	3.36%	-2.23%	-8.40%	-0.74%	-7.31%	-2.10%	5.55%	3.45%	-	6.91%	7.21%
Revenue Q/Q Growth	-9.25%	-3.23%	-1.55%	5.95%	13.71%	-11.12%	14.18%	5.00%	-	1.83%	20.65%
EBITDA Q/Q Growth	-49.96%	37.42%	-2.23%	-5.12%	38.38%	-13.28%	21.08%	-66.02%	-	10.93%	71.95%
EBIT Q/Q Growth	-64.84%	64.10%	-1.82%	-8.14%	62.44%	-20.30%	27.35%	-88.49%	-	16.39%	103.49%
NOPAT Q/Q Growth	-59.51%	48.82%	1.24%	-19.09%	37.73%	5.06%	13.25%	16.17%	-	25.19%	108.94%
Net Income Q/Q Growth	-58.34%	52.21%	-2.46%	-17.84%	35.72%	10.61%	9.93%	-79.38%	-	25.06%	103.89%
EPS Q/Q Growth	-57.43%	50.39%	-2.58%	-18.52%	38.31%	9.39%	9.87%	-79.30%	-	24.42%	109.81%
Operating Cash Flow Q/Q Growth	-54.62%	-70.17%	391.81%	-66.90%	156.96%	-76.50%	376.18%	-29.66%	-	-72.44%	316.98%
Free Cash Flow Firm Q/Q Growth	72.83%	354.24%	143.90%	-76.93%	285.32%	-51.61%	-150.07%	99.20%	-	35.86%	47.81%
Invested Capital Q/Q Growth	-0.47%	1.52%	-5.55%	4.00%	-7.06%	7.23%	1.83%	1.94%	-	4.59%	2.12%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.04%	31.32%	31.92%	31.15%	33.29%	32.77%	32.66%	29.68%	-	31.33%	34.33%
EBITDA Margin	8.50%	12.07%	11.99%	10.74%	13.06%	12.75%	13.52%	4.37%	-	11.32%	16.13%
Operating Margin	4.77%	8.20%	8.14%	7.07%	10.48%	8.84%	10.10%	7.37%	-	7.78%	13.12%
EBIT Margin	4.85%	8.23%	8.21%	7.11%	10.16%	9.11%	10.17%	1.11%	-	7.82%	13.19%
Profit (Net Income) Margin	4.33%	6.82%	6.75%	5.24%	6.25%	7.78%	7.49%	1.47%	-	5.98%	10.11%
Tax Burden Percent	90.54%	80.98%	83.93%	73.79%	60.30%	84.51%	73.39%	111.16%	-	73.61%	75.61%
Interest Burden Percent	98.63%	102.28%	98.05%	99.75%	101.98%	100.99%	100.38%	118.69%	-	103.95%	101.41%
Effective Tax Rate	9.46%	19.02%	16.07%	26.21%	39.70%	15.49%	26.62%	-11.16%	-	26.39%	24.39%
Return on Invested Capital (ROIC)	6.90%	9.55%	9.36%	7.00%	9.14%	10.49%	11.16%	12.58%	-	9.11%	16.43%
ROIC Less NNEP Spread (ROIC-NNEP)	6.96%	10.15%	8.81%	7.23%	10.47%	23.78%	10.44%	90.47%	-	6.39%	15.10%
Return on Net Nonoperating Assets (RNNOA)	0.57%	1.03%	0.43%	0.21%	-0.22%	0.19%	-0.44%	-3.11%	-	-0.23%	-0.98%
Return on Equity (ROE)	7.47%	10.58%	9.80%	7.21%	8.92%	10.69%	10.71%	9.47%	-	8.88%	15.46%
Cash Return on Invested Capital (CROIC)	12.14%	14.18%	18.29%	8.43%	16.63%	11.21%	4.60%	6.98%	-	2.75%	4.21%
Operating Return on Assets (OROA)	5.55%	8.71%	8.05%	6.79%	10.25%	9.30%	10.68%	1.20%	-	8.69%	14.69%
Return on Assets (ROA)	4.95%	7.21%	6.62%	5.00%	6.31%	7.94%	7.86%	1.58%	-	6.65%	11.26%
Return on Common Equity (ROCE)	7.47%	10.58%	9.80%	7.21%	8.92%	10.69%	10.71%	9.47%	-	8.88%	15.45%
Return on Equity Simple (ROE_SIMPLE)	0.00%	12.46%	9.71%	7.69%	0.00%	8.96%	0.00%	0.00%	-	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	6.29	9.36	9.48	7.67	11	11	13	15	8.07	10	21
NOPAT Margin	4.32%	6.64%	6.83%	5.22%	6.32%	7.47%	7.41%	8.20%	-	5.73%	9.92%
Net Nonoperating Expense Percent (NNEP)	-0.06%	-0.60%	0.55%	-0.23%	-1.33%	-13.28%	0.72%	-77.89%	-	2.73%	1.33%
Return On Investment Capital (ROIC_SIMPLE)	1.31%	-	-	-	2.34%	2.33%	2.53%	2.85%	1.57%	1.94%	3.93%
Cost of Revenue to Revenue	66.96%	68.68%	68.08%	68.85%	66.71%	67.23%	67.34%	70.32%	-	68.67%	65.67%
SG&A Expenses to Revenue	13.75%	11.79%	10.99%	11.17%	11.49%	11.87%	11.01%	10.75%	-	11.94%	10.12%
R&D to Revenue	3.91%	3.85%	3.86%	3.77%	3.34%	3.69%	3.36%	3.47%	-	3.82%	3.36%
Operating Expenses to Revenue	28.26%	23.12%	23.78%	24.08%	22.81%	23.93%	22.57%	22.30%	-	23.54%	21.21%
Earnings before Interest and Taxes (EBIT)	7.07	12	11	10	17	14	17	1.99	12	14	28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	12	17	17	16	22	19	23	7.79	18	20	34
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.56	1.52	1.47	1.46	1.48	1.59	1.71	2.07	-	2.80	4.06
Price to Tangible Book Value (P/TBV)	1.74	1.69	1.62	1.61	1.62	1.74	1.87	2.26	-	3.06	4.47
Price to Revenue (P/Rev)	0.97	1.00	1.04	1.10	1.05	1.15	1.25	1.45	-	1.90	2.71
Price to Earnings (P/E)	10.26	12.21	15.13	19.06	16.85	17.72	18.62	25.87	-	38.64	46.55
Dividend Yield	0.60%	0.62%	0.64%	0.63%	0.63%	0.57%	0.50%	0.41%	-	0.30%	0.20%
Earnings Yield	9.74%	8.19%	6.61%	5.25%	5.94%	5.64%	5.37%	3.87%	-	2.59%	2.15%
Enterprise Value to Invested Capital (EV/IC)	1.55	1.50	1.48	1.47	1.51	1.60	1.76	2.13	-	2.88	4.27
Enterprise Value to Revenue (EV/Rev)	0.98	1.03	1.03	1.09	1.00	1.13	1.20	1.41	-	1.87	2.66
Enterprise Value to EBITDA (EV/EBITDA)	6.37	7.43	8.52	10.08	8.37	9.26	9.54	13.11	-	18.98	24.65
Enterprise Value to EBIT (EV/EBIT)	7.80	9.66	12.02	15.39	11.83	12.94	13.02	18.84	-	29.05	35.43
Enterprise Value to NOPAT (EV/NOPAT)	10.17	12.41	14.81	19.00	16.07	17.44	18.05	20.89	-	31.55	39.51
Enterprise Value to Operating Cash Flow (EV/OCF)	6.12	7.36	6.29	9.94	8.84	10.06	11.48	12.40	-	17.64	27.34
Enterprise Value to Free Cash Flow (EV/FCFF)	12.95	10.43	7.71	17.33	8.73	14.13	39.25	31.05	-	108.30	104.79
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.15	0.15	0.09	0.10	0.07	0.09	0.08	0.10	-	0.10	0.09
Long-Term Debt to Equity	0.12	0.13	0.07	0.07	0.04	0.07	0.06	0.08	-	0.09	0.07
Financial Leverage	0.08	0.10	0.05	0.03	-0.02	0.01	-0.04	-0.03	-	-0.04	-0.06
Leverage Ratio	1.51	1.50	1.47	1.45	1.40	1.39	1.37	1.38	-	1.38	1.39
Compound Leverage Factor	1.49	1.53	1.44	1.44	1.43	1.40	1.38	1.64	-	1.43	1.41
Debt to Total Capital	13.01%	13.39%	8.48%	8.96%	6.34%	8.67%	7.29%	8.81%	-	9.11%	7.96%
Short-Term Debt to Total Capital	2.81%	1.79%	2.14%	2.25%	2.26%	1.93%	1.68%	1.47%	-	1.38%	1.28%
Long-Term Debt to Total Capital	10.20%	11.59%	6.34%	6.70%	4.07%	6.73%	5.61%	7.34%	-	7.72%	6.68%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	-	0.01%	0.01%
Common Equity to Total Capital	86.99%	86.61%	91.52%	91.04%	93.66%	91.32%	92.70%	91.19%	-	90.88%	92.03%
Debt to EBITDA	0.60	0.73	0.55	0.68	0.40	0.57	0.46	0.63	-	0.69	0.53
Net Debt to EBITDA	0.08	0.21	-0.13	-0.09	-0.40	-0.18	-0.39	-0.39	-	-0.32	-0.42
Long-Term Debt to EBITDA	0.47	0.64	0.41	0.51	0.26	0.44	0.35	0.53	-	0.59	0.45
Debt to NOPAT	0.96	1.23	0.95	1.29	0.77	1.06	0.86	1.00	-	1.15	0.86
Net Debt to NOPAT	0.13	0.35	-0.22	-0.16	-0.77	-0.35	-0.73	-0.62	-	-0.53	-0.67
Long-Term Debt to NOPAT	0.75	1.06	0.71	0.96	0.49	0.83	0.66	0.84	-	0.97	0.72
Altman Z-Score	4.87	5.03	5.17	5.04	5.39	5.52	5.59	5.99	-	7.05	8.81
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.01%	-	0.01%	0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.92	3.15	2.93	2.81	2.91	3.08	3.08	3.09	-	3.01	2.99
Quick Ratio	0.96	1.12	1.43	0.97	1.03	1.12	1.08	1.04	-	1.06	1.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-7.57	19	47	11	42	20	-10	-0.08	-30	-19	-10
Operating Cash Flow to CapEx	238.45%	844.79%	785.94%	271.79%	693.57%	51.95%	321.64%	182.19%	-	60.81%	364.33%
Free Cash Flow to Firm to Interest Expense	-10.71	27.18	82.64	19.20	109.50	53.69	-31.78	-0.26	-	-82.65	-41.88
Operating Cash Flow to Interest Expense	27.28	8.13	49.81	16.61	63.17	15.04	84.68	60.71	-	26.06	105.50
Operating Cash Flow Less CapEx to Interest Expense	15.84	7.16	43.48	10.50	54.06	-13.91	58.35	27.38	-	-16.80	76.54
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.14	1.06	0.98	0.95	1.01	1.02	1.05	1.07	-	1.11	1.11
Accounts Receivable Turnover	5.77	4.98	4.76	4.83	5.44	5.23	5.61	5.73	-	5.59	5.38
Inventory Turnover	2.94	2.86	2.72	2.67	2.90	2.94	2.99	3.12	-	3.36	3.49
Fixed Asset Turnover	3.50	3.15	2.92	2.84	2.95	2.96	3.07	3.17	-	3.25	3.37
Accounts Payable Turnover	10.28	8.49	8.50	8.31	10.13	9.36	9.07	9.88	-	9.45	9.48
Days Sales Outstanding (DSO)	63.27	73.33	76.67	75.56	67.10	69.81	65.05	63.74	-	65.28	67.82
Days Inventory Outstanding (DIO)	124.35	127.77	134.11	136.84	125.94	124.03	121.96	116.92	-	108.64	104.72
Days Payable Outstanding (DPO)	35.52	43.00	42.96	43.94	36.03	39.01	40.23	36.96	-	38.63	38.50
Cash Conversion Cycle (CCC)	152.09	158.11	167.83	168.46	157.01	154.83	146.77	143.71	-	135.29	134.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	426	433	409	425	395	423	431	440	433	453	462
Invested Capital Turnover	1.60	1.44	1.37	1.34	1.45	1.40	1.51	1.53	-	1.59	1.66
Increase / (Decrease) in Invested Capital	14	-9.89	-37	-3.16	-31	-9.09	23	15	38	29	31
Enterprise Value (EV)	659	647	603	623	596	678	758	937	-	1,303	1,972
Market Capitalization	650	629	612	628	625	691	789	965	-	1,325	2,006
Book Value per Share	$85.04	$84.29	$84.63	$87.30	$86.23	$88.20	$93.26	$94.68	$97.01	$96.70	$101.17
Tangible Book Value per Share	$76.36	$76.04	$76.71	$79.23	$78.81	$80.61	$85.27	$86.53	$88.68	$88.49	$91.79
Total Capital	478	477	455	471	451	477	497	511	515	521	537
Total Debt	62	64	39	42	29	41	36	45	39	47	43
Total Long-Term Debt	49	55	29	32	18	32	28	38	33	40	36
Net Debt	8.64	18	-8.85	-5.30	-29	-13	-31	-28	-44	-22	-33
Capital Expenditures (CapEx)	8.09	0.68	3.60	3.45	3.47	11	8.37	10	10	9.94	6.92
Debt-free, Cash-free Net Working Capital (DFCFNWC)	173	177	163	170	160	175	180	178	172	186	195
Debt-free Net Working Capital (DFNWC)	227	223	211	217	218	230	247	251	255	255	271
Net Working Capital (NWC)	213	215	201	207	207	221	238	244	249	248	264
Net Nonoperating Expense (NNE)	-0.02	-0.24	0.11	-0.03	0.12	-0.46	-0.13	12	-0.37	-0.45	-0.41
Net Nonoperating Obligations (NNO)	9.94	19	-7.63	-4.04	-27	-12	-30	-27	-43	-21	-32
Total Depreciation and Amortization (D&A)	5.31	5.41	5.25	5.32	4.85	5.40	5.69	5.81	6.14	6.17	6.25
Debt-free, Cash-free Net Working Capital to Revenue	25.88%	28.19%	27.90%	29.67%	27.01%	29.13%	28.44%	26.89%	-	26.62%	26.30%
Debt-free Net Working Capital to Revenue	33.89%	35.49%	36.00%	37.97%	36.65%	38.25%	39.03%	37.89%	-	36.58%	36.59%
Net Working Capital to Revenue	31.88%	34.12%	34.34%	36.11%	34.93%	36.72%	37.71%	36.76%	-	35.55%	35.67%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.32	$1.95	$1.91	$1.57	$2.13	$2.34	$2.58	$0.53	$1.72	$2.15	$4.51
Adjusted Weighted Average Basic Shares Outstanding	4.92M	4.92M	4.92M	4.90M	4.91M	4.93M	4.93M	4.92M	4.92M	4.91M	4.77M
Adjusted Diluted Earnings per Share	$1.29	$1.94	$1.89	$1.54	$2.13	$2.33	$2.56	$0.53	$1.72	$2.14	$4.49
Adjusted Weighted Average Diluted Shares Outstanding	5.00M	4.94M	4.96M	4.98M	4.95M	4.95M	4.96M	4.94M	4.94M	4.93M	4.79M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.90M	4.92M	4.91M	4.90M	4.94M	4.94M	4.92M	4.90M	4.90M	4.89M	4.89M
Normalized Net Operating Profit after Tax (NOPAT)	6.29	9.36	9.48	7.67	11	11	13	9.19	8.07	10	21
Normalized NOPAT Margin	4.32%	6.64%	6.83%	5.22%	6.32%	7.47%	7.41%	5.16%	-	5.73%	9.92%
Pre Tax Income Margin	4.79%	8.42%	8.05%	7.10%	10.36%	9.20%	10.20%	1.32%	-	8.13%	13.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.99	16.38	20.04	18.54	44.58	36.00	54.21	6.36	-	59.42	117.37
NOPAT to Interest Expense	8.90	13.22	16.68	13.60	27.72	29.51	39.52	46.79	-	43.52	88.27
EBIT Less CapEx to Interest Expense	-1.45	15.41	13.70	12.43	35.47	7.05	27.89	-26.96	-	16.56	88.41
NOPAT Less CapEx to Interest Expense	-2.54	12.26	10.35	7.49	18.61	0.56	13.19	13.47	-	0.66	59.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	6.48%	7.92%	10.09%	12.36%	10.98%	10.52%	9.70%	11.03%	-	11.86%	9.53%
Augmented Payout Ratio	36.31%	47.91%	47.37%	38.89%	34.17%	30.91%	32.69%	43.26%	-	77.52%	63.93%

Financials Breakdown Chart

Key Financial Trends

Preformed Line Products (NASDAQ: PLPC) has shown solid profitability and improving top-line momentum in early 2026, but the latest quarter also highlights pressure from working capital, capital spending, and ongoing shareholder payouts.

In Q1 2026, PLPC reported revenue of $176.3 million, up modestly from $173.1 million in Q4 2025 and $148.5 million in Q1 2025. Net income attributable to common shareholders came in at $10.5 million, or $2.14 per diluted share, versus $8.4 million and $1.72 per diluted share in the prior quarter. That’s a clear improvement year over year and sequentially.

At the same time, the company’s cash flow was weaker in the latest quarter. Operating cash flow fell to $6.0 million in Q1 2026 from $21.9 million in Q4 2025, as working capital consumed cash. PLPC also spent nearly $10.0 million on property, plant and equipment, while continuing to repurchase shares and pay dividends. That combination helped drive a $13.9 million decline in cash and equivalents for the quarter.

Over the last several years, PLPC has generally maintained a profitable profile, with revenue trending higher from the 2024 period into 2025 and early 2026. Gross profit has remained strong, but operating expenses have also risen, especially marketing and SG&A. The business still appears capable of generating earnings, though quarterly cash conversion can be uneven.

Revenue is moving higher year over year. Q1 2026 revenue of $176.3 million was above $148.5 million in Q1 2025, showing healthy growth.
Profitability remains intact. PLPC posted $10.5 million in net income in Q1 2026 and $2.14 diluted EPS.
Gross profit is still substantial. Q1 2026 gross profit of $55.2 million implies a strong gross margin profile.
Balance sheet equity remains sizable. Total common equity was $473.5 million at the end of Q1 2026.
Long-term operating assets are expanding. Net PP&E rose to $225.3 million from $203.1 million a year earlier, suggesting continued investment in capacity.
Shares outstanding are relatively stable. Diluted weighted average shares were 4.93 million in Q1 2026, only slightly above prior periods.
PLPC continues to return capital to shareholders. The company paid $0.21 per share in dividends in Q1 2026 and also repurchased stock.
Liquidity remains supported by current assets. Total current assets were $371.4 million, led by receivables, inventory, and restricted cash.
Operating cash flow weakened sharply in Q1 2026. Cash from operations dropped to $6.0 million from $21.9 million in Q4 2025.
Working capital consumed cash. Changes in operating assets and liabilities reduced cash by $13.4 million in the quarter.

Looking at the broader trend, PLPC’s revenue has improved from the weaker 2024 base, and profits have generally recovered as well. However, the company’s cash generation has been more volatile than earnings, with large swings driven by working capital, debt activity, and capital spending. Investors should watch whether operating cash flow can stay closer to earnings over the next few quarters.

Bottom line: PLPC looks fundamentally profitable and still appears to be growing modestly, but the latest quarter shows that cash flow is less consistent than earnings. That makes the stock look like a steady operator rather than a high-growth story, with execution on working capital and capital spending likely to matter for the next leg of performance.

07/31/26 02:16 PM ETAI Generated. May Contain Errors.

Preformed Line Products Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Preformed Line Products' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Preformed Line Products' net income appears to be on an upward trend, with a most recent value of $35.31 million in 2025, rising from $6.68 million in 2015. The previous period was $37.11 million in 2024. Find out what analysts predict for Preformed Line Products in the coming months.

Preformed Line Products' total operating income in 2025 was $55.14 million, based on the following breakdown:

Total Gross Profit: $208.54 million
Total Operating Expenses: $153.40 million

Over the last 10 years, Preformed Line Products' total revenue changed from $354.67 million in 2015 to $669.34 million in 2025, a change of 88.7%.

Preformed Line Products' total liabilities were at $178.07 million at the end of 2025, a 17.5% increase from 2024, and a 70.6% increase since 2015.

Over the last 10 years, Preformed Line Products' book value per share changed from 41.54 in 2015 to 97.01 in 2025, a change of 133.5%.

Related Companies

Financial statements for NASDAQ:PLPC last updated on 7/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Preformed Line Products (PLPC) Financials

Financials Breakdown Chart

Key Financial Trends

Preformed Line Products Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Preformed Line Products (PLPC) Financials

Annual Income Statements for Preformed Line Products

Quarterly Income Statements for Preformed Line Products

Annual Cash Flow Statements for Preformed Line Products

Quarterly Cash Flow Statements for Preformed Line Products

Annual Balance Sheets for Preformed Line Products

Quarterly Balance Sheets for Preformed Line Products

Annual Metrics And Ratios for Preformed Line Products

Quarterly Metrics And Ratios for Preformed Line Products

Financials Breakdown Chart

Key Financial Trends

Preformed Line Products Financials - Frequently Asked Questions

When does Preformed Line Products' financial year end?

How has Preformed Line Products' net income changed over the last 10 years?

What is Preformed Line Products' operating income?

How has Preformed Line Products' revenue changed over the last 10 years?

How much debt does Preformed Line Products have?

How has Preformed Line Products' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools